The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Fatty Liver Treatment Market Research Report 2025
Synopsis
Fatty liver disease is one of the most common liver dysfunction where the triglyceride fat accumulates in liver cells.
The global Fatty Liver Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Fatty Liver Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fatty Liver Treatment.
Report Scope
The Fatty Liver Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fatty Liver Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fatty Liver Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cardax
Daewoong
Roche
Glenmark
GW
Limerick BioPharma
Merck
Novartis
Orchid
AstraZeneca
Segment by Type
Thiazolidinedione
Vitamin E
Metformin Statins
Polyunsaturated Fatty Acids
Angiotensin Receptor Blockers
Pentoxifylline
Segment by Application
Hospitals and Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fatty Liver Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Fatty liver disease is one of the most common liver dysfunction where the triglyceride fat accumulates in liver cells.
The global Fatty Liver Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Fatty Liver Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fatty Liver Treatment.
Report Scope
The Fatty Liver Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fatty Liver Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fatty Liver Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cardax
Daewoong
Roche
Glenmark
GW
Limerick BioPharma
Merck
Novartis
Orchid
AstraZeneca
Segment by Type
Thiazolidinedione
Vitamin E
Metformin Statins
Polyunsaturated Fatty Acids
Angiotensin Receptor Blockers
Pentoxifylline
Segment by Application
Hospitals and Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fatty Liver Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fatty Liver Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Thiazolidinedione
1.2.3 Vitamin E
1.2.4 Metformin Statins
1.2.5 Polyunsaturated Fatty Acids
1.2.6 Angiotensin Receptor Blockers
1.2.7 Pentoxifylline
1.3 Market by Application
1.3.1 Global Fatty Liver Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and Clinics
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fatty Liver Treatment Market Perspective (2019-2030)
2.2 Fatty Liver Treatment Growth Trends by Region
2.2.1 Global Fatty Liver Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Fatty Liver Treatment Historic Market Size by Region (2019-2024)
2.2.3 Fatty Liver Treatment Forecasted Market Size by Region (2025-2030)
2.3 Fatty Liver Treatment Market Dynamics
2.3.1 Fatty Liver Treatment Industry Trends
2.3.2 Fatty Liver Treatment Market Drivers
2.3.3 Fatty Liver Treatment Market Challenges
2.3.4 Fatty Liver Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fatty Liver Treatment Players by Revenue
3.1.1 Global Top Fatty Liver Treatment Players by Revenue (2019-2024)
3.1.2 Global Fatty Liver Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Fatty Liver Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fatty Liver Treatment Revenue
3.4 Global Fatty Liver Treatment Market Concentration Ratio
3.4.1 Global Fatty Liver Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fatty Liver Treatment Revenue in 2023
3.5 Fatty Liver Treatment Key Players Head office and Area Served
3.6 Key Players Fatty Liver Treatment Product Solution and Service
3.7 Date of Enter into Fatty Liver Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fatty Liver Treatment Breakdown Data by Type
4.1 Global Fatty Liver Treatment Historic Market Size by Type (2019-2024)
4.2 Global Fatty Liver Treatment Forecasted Market Size by Type (2025-2030)
5 Fatty Liver Treatment Breakdown Data by Application
5.1 Global Fatty Liver Treatment Historic Market Size by Application (2019-2024)
5.2 Global Fatty Liver Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Fatty Liver Treatment Market Size (2019-2030)
6.2 North America Fatty Liver Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Fatty Liver Treatment Market Size by Country (2019-2024)
6.4 North America Fatty Liver Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fatty Liver Treatment Market Size (2019-2030)
7.2 Europe Fatty Liver Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Fatty Liver Treatment Market Size by Country (2019-2024)
7.4 Europe Fatty Liver Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fatty Liver Treatment Market Size (2019-2030)
8.2 Asia-Pacific Fatty Liver Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Fatty Liver Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Fatty Liver Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fatty Liver Treatment Market Size (2019-2030)
9.2 Latin America Fatty Liver Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Fatty Liver Treatment Market Size by Country (2019-2024)
9.4 Latin America Fatty Liver Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fatty Liver Treatment Market Size (2019-2030)
10.2 Middle East & Africa Fatty Liver Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Fatty Liver Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Fatty Liver Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cardax
11.1.1 Cardax Company Detail
11.1.2 Cardax Business Overview
11.1.3 Cardax Fatty Liver Treatment Introduction
11.1.4 Cardax Revenue in Fatty Liver Treatment Business (2019-2024)
11.1.5 Cardax Recent Development
11.2 Daewoong
11.2.1 Daewoong Company Detail
11.2.2 Daewoong Business Overview
11.2.3 Daewoong Fatty Liver Treatment Introduction
11.2.4 Daewoong Revenue in Fatty Liver Treatment Business (2019-2024)
11.2.5 Daewoong Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Fatty Liver Treatment Introduction
11.3.4 Roche Revenue in Fatty Liver Treatment Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Glenmark
11.4.1 Glenmark Company Detail
11.4.2 Glenmark Business Overview
11.4.3 Glenmark Fatty Liver Treatment Introduction
11.4.4 Glenmark Revenue in Fatty Liver Treatment Business (2019-2024)
11.4.5 Glenmark Recent Development
11.5 GW
11.5.1 GW Company Detail
11.5.2 GW Business Overview
11.5.3 GW Fatty Liver Treatment Introduction
11.5.4 GW Revenue in Fatty Liver Treatment Business (2019-2024)
11.5.5 GW Recent Development
11.6 Limerick BioPharma
11.6.1 Limerick BioPharma Company Detail
11.6.2 Limerick BioPharma Business Overview
11.6.3 Limerick BioPharma Fatty Liver Treatment Introduction
11.6.4 Limerick BioPharma Revenue in Fatty Liver Treatment Business (2019-2024)
11.6.5 Limerick BioPharma Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Fatty Liver Treatment Introduction
11.7.4 Merck Revenue in Fatty Liver Treatment Business (2019-2024)
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Fatty Liver Treatment Introduction
11.8.4 Novartis Revenue in Fatty Liver Treatment Business (2019-2024)
11.8.5 Novartis Recent Development
11.9 Orchid
11.9.1 Orchid Company Detail
11.9.2 Orchid Business Overview
11.9.3 Orchid Fatty Liver Treatment Introduction
11.9.4 Orchid Revenue in Fatty Liver Treatment Business (2019-2024)
11.9.5 Orchid Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Detail
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Fatty Liver Treatment Introduction
11.10.4 AstraZeneca Revenue in Fatty Liver Treatment Business (2019-2024)
11.10.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
